m22 multi-application platform (Lumenis Inc)
90
Structured Review
Lumenis Inc
m22 multi-application platform
M22 Multi Application Platform, supplied by Lumenis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m22+multi-application+platform/m22+multi+application+platform/pm26711809-52-8-11
Average 90 stars, based on 1 article reviews
M22 Multi Application Platform, supplied by Lumenis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m22+multi-application+platform/m22+multi+application+platform/pm26711809-52-8-11
Average 90 stars, based on 1 article reviews
m22 multi-application platform - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Treatment of facial photodamage and rhytides using a novel 1,565 nm non-ablative fractional erbium-doped fiber laser. Article Snippet: Background and Objective: Non-ablative fractional lasers (NAFL) generate microscopic non-contiguous columns of thermal injury in the dermis, resulting in collagen remodeling.. This manuscript details our experience with a novel 1,565nm scanned, erbium-doped fiber NAFL for the treatment of facial photodamage.. Study Design/Materials and Methods: A prospective, open-label clinical trial was conducted at two clinical sites in the United States on 16 female subjects with a mean age of 49.6 years, Fitzpatrick skin types II to IV, and a baseline Fitzpatrick–Goldman Wrinkle and Elastosis Score (FGWES) of 3–6. |